Ritalin is a prescription drug used in the treatment of ADD (Attention Deficit Disorder) and ADHD (Attention Deficit Hyperactive Disorder). This product is one of the brand names of Methylphenidate. The company behind this product is Novartis, a global pharmaceutical company with its headquarters in Basel, Switzerland. Novartis was founded in 1996 through the merger of Sandoz and Ciba-Geigy, two companies with a long corporate history.
According to the company, this product is one of their most important products and has been in the news over the past 10 years as a result of its use as a treatment for ADD, ADHD and narcolepsy. Ritalin was created to calm individuals with both disorders and improves their quality of concentration and brain functionality.
Ritalin contains: D&C Yellow No. 10, FD&C Green No. 3, lactose, magnesium stearate, polyethylene glycol, starch, sucrose, talc, and tragacanth
Ritalin, just like many other generic methylphenidate tablets, comes in 5, 10 and 20 mg doses. According to the producing company, the recommended starting dose is 5 mg, twice a day but the prescribed dosage may increase rapidity.
The manufacturer claims that Ritalin is a stimulant that works with the central nervous system to calm down sufferers of ADHD and ADD. The drug may reduce impulsive behavior and it may allow children and adults alike to function better in social situations.
A red flag for us was represented by several clinical studies conducted as a result of reports that Ritalin has caused death of some children. The results of these studies remained inconclusive but, while the drug is still FDA approved, the chemical composition has been associated with some severe side effects: agitation, nervousness, anxiety, loss of appetite, vomiting, insomnia, nausea, palpitations, dizziness, headache, strokes and heart failure, increased heart rate, increased blood pressure, psychosis, abnormal liver function and hallucinations.
Because the drug was first approved before modern double blind placebo trials were required by the FDA, the producing company has never had to publish any results of its effectiveness. While the drug’s safety for short-term usage has been already established, its long-term effects are still unknown.
- The product is on the market for more than 10 years;
- The company provides a complete documentation on this product;
- Ritalin may be a truly useful treatment for ADD and ADHD sufferers.
- There have been reported severe side effects: agitation, nervousness, anxiety, loss of appetite, vomiting, insomnia, nausea, palpitations, dizziness, headache, strokes and heart failure, increased heart rate, increased blood pressure, psychosis, abnormal liver function and hallucinations;
- The long-term effects of this drug are still unknown;
- The company has never published any results of its effectiveness;
- It is a highly addictive drug, being classified as a Schedule II substance, along with cocaine, morphine, methadone, opium, Desoxyn, Dexedrine, Percodan, Preludin, Dilaudid, and Demoral.
A question that was asked in the past few years is what to do with a drug that is helpful to so many, but almost certainly is over-used and even abused in many situations. Many clinicians are recommending, as a possible solution, a better control of its use. According to many specialists, the producing company should conduct some complex researches to establish the drug’s long-term effects and pediatricians and others who work with children must be better trained in the assessment of ADD/ADHD.
Only after these problems are solved, Ritalin can fulfill its potential as a truly useful treatment for a serious condition in modern-day society.
We recommend extreme caution before taking this treatment. This product is currently classified by the Drug Enforcement Administration (DEA) and the U.S. Food and Drug Administration (FDA) as a Schedule II substance, along with cocaine, morphine, methadone, opium, Desoxyn, Dexedrine, Percodan, Preludin, Dilaudid and Demoral. It can cause addiction and severe withdrawal symptoms.
10yrs or More
|HCF Quality (4.8)||(4.8)|
|Ginkoba Memory (3.3)||(3.3)|
|Razadyne ER (2.3)||(2.3)||N/A|